Aurobindo Pharma surges on receiving USFDA’s nod to manufacture Ondansetron Injection

24 Dec 2012 Evaluate

Aurobindo Pharma is currently trading at Rs. 196.20, up by 3.80 points or 1.98% from its previous closing of Rs. 192.40 on the BSE.

The scrip opened at Rs. 193.95 and has touched a high and low of Rs. 196.70 and Rs. 192.75 respectively. So far 121614 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 201.40 on 05-Dec-2012 and a 52 week low of Rs. 83.35 on 29-Dec-2011.

Last one week high and low of the scrip stood at Rs. 198.95 and Rs. 181.10 respectively. The current market cap of the company is Rs. 5721.99 crore.

The promoters holding in the company stood at 54.76% while Institutions and Non-Institutions held 29.33% and 15.91% respectively.

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Ondansetron Injection USP 2rng/mL packaged in 40mg/20mL Multiple-dose Vials (ANDA 202599) and Ondansetron Injection USP 2mg/mL packaged in 4mg/2mL Single-dose Vials, Preservative-free (ANDA 202600).

Importantly, these are the first ANDA’s to be approved out of Unit IV formulation facility in Hyderabad, India for manufacturing general liquid injectable and ophthalmic products and will be marketed and sold by  Aurobindo's wholly owned subsidiary AuroMedics Pharma LLC. Further, these products are ready for launch.

The approved Ondansetron Injections are the generic equivalent of GlaxoSmithKline’s Zofran Injection and indicated for prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy or postoperative nausea and/or vomiting.

Aurobindo Pharma, headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil.

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×